Top Markets
Coin of the day
Caliber Imaging & Diagnostics, Inc. Caliber Imaging & Diagnostics, Inc.

Caliber Imaging & Diagnostics, Inc.

LCDX
Rank in Stocks #42076
Caliber Imaging & Diagnostics, Inc. is a U.S.-based medical technology firm... Caliber Imaging & Diagnostics, Inc. is a U.S.-based medical technology firm that develops, manufactures, and markets advanced imaging solutions designed to visualize tissue at a cellular resolution. Their product line features the VivaScope 1500, a reflectance confocal imaging system that empowers medical practitioners and scientists to capture detailed confocal images depicting the cellular architecture of living tissue. They also provide the VivaScope 3000, a handheld in vivo reflectance confocal microscope tailored for dermatological imaging. Complementing its hardware, the firm offers VivaScan software, which streamlines patient scheduling, facilitates multi-lesion imaging during appointments, and assists with image review and reporting. Additionally, they supply VivaNet, a sophisticated digital telepathology system. Initially established as Lucid, Inc. in 1991, the company rebranded as Caliber Imaging & Diagnostics, Inc. in August 2012 and is headquartered in Andover, Massachusetts.
Share Price
$0.0006
Last synced: 2026-08-11
Market Cap
$5.10K
Change (1 day)
0.00%
Change (1 year)
500.00%
Country
US
Trade Caliber Imaging & Diagnostics, Inc. (LCDX)

Category

Earnings for Caliber Imaging & Diagnostics, Inc. (LCDX)
Earnings in 2026 TTM: 0
According to Caliber Imaging & Diagnostics, Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Caliber Imaging & Diagnostics, Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
$7.51B -
US
$5.15B -
US
$5.56B -
IE
$3.86B -
US
$1.42B -
US